Author

Kwame Twumasi‐Boateng

Observed names: K. Twumasi-Boateng, Kwame Twumasi-Boateng

Institution: Telix Pharmaceuticals Limited (Australia)

Observed institutions: BC Cancer Agency, University of British Columbia, Simon Fraser University, University of Victoria, Telix Pharmaceuticals Limited (Australia), McGill University, University of California, Berkeley

ORCID: 0009-0005-1209-036X

Observed ORCID: 0009-0005-1209-036X

OpenAlex ID: A5032796888

Oncolytic viruses as engineering platforms for combination immunotherapy

2018 · Kwame Twumasi-Boateng, Jessica L. Pettigrew, et al. · Nature reviews. Cancer · 445

Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer

2013 · Darin A. Wick, John R. Webb, et al. · Clinical Cancer Research · 157

Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines

2016 · Spencer D. Martin, Scott D. Brown, et al. · PLoS ONE · 143

PDF

Transcriptional Profiling Identifies a Role for BrlA in the Response to Nitrogen Depletion and for StuA in the Regulation of Secondary Metabolite Clusters in Aspergillus fumigatus

2008 · Kwame Twumasi-Boateng, Yan Yu, et al. · Eukaryotic Cell · 123

Oncolytic vesicular stomatitis virus expressing interferon-σ has enhanced therapeutic activity

2016 · Marie-Claude Bourgeois-Daigneault, Dominic Guy Roy, et al. · Molecular Therapy — Oncolytics · 99

PDF

The Developmental Intestinal Regulator ELT-2 Controls p38-Dependent Immune Responses in Adult C. elegans

2015 · Dena H. S. Block, Kwame Twumasi-Boateng, et al. · PLoS Genetics · 56

PDF

Publisher Correction: Oncolytic viruses as engineering platforms for combination immunotherapy

2018 · Kwame Twumasi-Boateng, Jessica L. Pettigrew, et al. · Nature reviews. Cancer · 46

PDF

An age‐dependent reversal in the protective capacities of JNK signaling shortens Caenorhabditis elegans lifespan

2012 · Kwame Twumasi‐Boateng, Tim W. Wang, et al. · Aging Cell · 44

PDF

FOS-1 functions as a transcriptional activator downstream of the C. elegans JNK homolog KGB-1

2016 · Zhe Zhang, Limeng Liu, et al. · Cellular Signalling · 28

Towards effective CAIX-targeted radionuclide and checkpoint inhibition combination therapy for advanced clear cell renal cell carcinoma

2024 · Simone C. Kleinendorst, Egbert Oosterwijk, et al. · Theranostics · 23

PDF

Dissociation of Immune Responses from Pathogen Colonization Supports Pattern Recognition in C. elegans

2012 · Kwame Twumasi-Boateng, Michael Shapira · PLoS ONE · 19

PDF

Automated Separation of C. elegans Variably Colonized by a Bacterial Pathogen

2014 · Kwame Twumasi-Boateng, Maureen Berg, et al. · Journal of Visualized Experiments · 2

PDF

640 Targeted alpha therapy with 225 Ac-hGirentuximab (TLX252) induces adaptive immune resistance via NKG2A/Qa-1 b axis

2026 · Riad Ladjohounlou, Yujuan Wang, et al. · Journal for ImmunoTherapy of Cancer

PDF

Influence of immune checkpoint inhibitor target and timing on combination treatment with antibody-based β-emitting targeted radionuclide therapy across tumor immunogenicity profiles

2026 · Simone C. Kleinendorst, Egbert Oosterwijk, et al. · Frontiers in Immunology

PDF

Abstract C090: Development of a multi-functional CAIX-TGFβ targeted radiopharmaceutical for triple-negative breast cancer

2025 · Wonjong Jin, Paul A. Clark, et al. · Molecular Cancer Therapeutics

268 Enhanced radiation therapy outcomes via TGFβ inhibition in the tumor microenvironment using bifunctional antibody TLX250-TRAP

2025 · Ria Kumari, Wonjong Jin, et al. · Radiotherapy and Oncology

Supplementary Figure Legend from Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer